Is AI Drug Discovery Actually Working? What the 2026 Clinical Trial Data Shows
Dr. Dereck Mush, MD, MBA
XtalPi
Combines quantum physics, artificial intelligence, and robotics for molecule discovery.
What they do
XtalPi provides an integrated platform combining cloud-based quantum physics algorithms, machine learning, and automated robotic wet-labs. Pharmaceutical and materials science enterprises purchase their platform services to predict crystal structures and optimize the development of solid-state drug formulations.
The record
- Vertical
- Pharma & Drug Discovery
- Sub-segment
- AI drug discovery
- Product type
- Platform software
- Stage
- Public
- Headquarters
- Shenzhen, China
- Region
- Asia-Pacific
- Founded
- 2014
- Total funding
- $786M raised
Notable investors: Tencent Holdings, Sequoia Capital China, SoftBank Vision Fund, 5Y Capital.
Also in Pharma & Drug Discovery
Related on The Signal
Dr. Dereck Mush, MD, MBA
What Pharma Is Buying From AI Drug Discovery: Inside AstraZeneca’s insitro Deal
Dr. Dereck Mush, MD, MBAThe HealthTech Signal
Chai Discovery triples its valuation as pharma buys into AI-designed molecules
Chai Discovery triples its valuation as pharma buys into AI-designed molecules
Dr. Dereck Mush, MD, MBA
AI is moving upstream, from molecule design into disease target identification itself
Dr. Dereck Mush, MD, MBA